Case series reveals no recurrences with Mohs micrographic surgery for dermatofibrosarcoma protuberans, suggesting effective treatment access improvements are needed.
This is the first Australian case series on MMS for DFSP. Our findings demonstrate no recurrences with follow-up and demonstrate that MMS may achieve clearance with smaller clinical margins than WLE. These results support international guidelines recommending MMS as the gold-standard treatment and highlight the need to improve access to MMS in Australia.
No takes yet. Share an insight, caveat, or question.
Johns et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: